Amerika Serikat - Inggris - NLM (National Library of Medicine)

abbvie inc. - ribavirin (unii: 49717awg6k) (ribavirin - unii:49717awg6k) - ribavirin 200 mg

Kanada - Inggris - Health Canada

abbvie corporation - ribavirin - tablet - 200mg - ribavirin 200mg - nucleosides and nucleotides

Kanada - Inggris - Health Canada

abbvie corporation - ribavirin - tablet - 400mg - ribavirin 400mg - nucleosides and nucleotides

Kanada - Inggris - Health Canada

abbvie corporation - ribavirin - tablet - 600mg - ribavirin 600mg - nucleosides and nucleotides

Kanada - Inggris - Health Canada

pendopharm division of pharmascience inc - ribavirin - tablet - 400mg - ribavirin 400mg - nucleosides and nucleotides

Kanada - Inggris - Health Canada

pendopharm division of pharmascience inc - ribavirin - tablet - 600mg - ribavirin 600mg - nucleosides and nucleotides

Kanada - Inggris - Health Canada

pendopharm division of pharmascience inc - ribavirin - tablet - 200mg - ribavirin 200mg - nucleosides and nucleotides

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

laboratorios liconsa, s.a. - ibandronic acid - film-coated tablet - 150 milligram(s) - bisphosphonates; ibandronic acid

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

viatris limited - eptifibatide 0.75 mg/ml (75 mg in 100 ml) - solution for infusion - 0.75 mg/ml - active: eptifibatide 0.75 mg/ml (75 mg in 100 ml) excipient: citric acid monohydrate sodium hydroxide water for injection - indicated for patients undergoing non-urgent, percutaneous coronary intervention (pci) with coronary stenting for the reduction of death, myocardial infarction, urgent revascularisation and the need for acute antithrombotic rescue therapy. indicated for the reduction of death and myocardial infarction in patients presenting with unstable angina or non-q-wave myocardial infarction. indicated in patients who are managed with standard medical therapies and/or with percutaneous coronary intervention. eptifibatide is intended for use with aspirin, heparin or clopidigrel.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

viatris limited - eptifibatide 2 mg/ml (20 mg in 10 ml) - solution for injection - 2 mg/ml - active: eptifibatide 2 mg/ml (20 mg in 10 ml) excipient: citric acid monohydrate sodium hydroxide water for injection - indicated for patients undergoing non-urgent, percutaneous coronary intervention (pci) with coronary stenting for the reduction of death, myocardial infarction, urgent revascularisation and the need for acute antithrombotic rescue therapy. indicated for the reduction of death and myocardial infarction in patients presenting with unstable angina or non-q-wave myocardial infarction. indicated in patients who are managed with standard medical therapies and/or with percutaneous coronary intervention. eptifibatide is intended for use with aspirin, heparin or clopidigrel.